Search Results - "He, Maotao"
-
1
Prenatal GABAB Receptor Agonist Administration Corrects the Inheritance of Autism-Like Core Behaviors in Offspring of Mice Prenatally Exposed to Valproic Acid
Published in Frontiers in psychiatry (15-04-2022)“…This study was performed to evaluate the effects of prenatal baclofen (a GABAB receptor agonist) treatment on the inheritance of autism-like behaviors in…”
Get full text
Journal Article -
2
Deletion of Mitochondrial Uncoupling Protein 2 Exacerbates Mitochondrial Damage in Mice Subjected to Cerebral Ischemia and Reperfusion Injury under both Normo- and Hyperglycemic Conditions
Published in International journal of biological sciences (01-01-2020)“…Deletion of mitochondrial uncoupling protein 2 (UCP2) has been shown to aggravate ischemic damage in the brain. However, the underlying mechanisms are not…”
Get full text
Journal Article -
3
Repurposed genipin targeting UCP2 exhibits antitumor activity through inducing ferroptosis in glioblastoma
Published in Acta biochimica et biophysica Sinica (11-11-2024)“…Uncoupling protein-2 (UCP2) controls the antioxidant response and redox homeostasis in cancer and is considered a potent molecular target for cancer treatment…”
Get full text
Journal Article -
4
A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR
Published in Cellular and molecular life sciences : CMLS (01-11-2022)“…Pathophysiology associated with Huntington’s disease (HD) has been studied extensively in various cell and animal models since the 1993 discovery of the mutant…”
Get full text
Journal Article -
5
The GABAB receptor agonist STX209 reverses the autism‑like behaviour in an animal model of autism induced by prenatal exposure to valproic acid
Published in Molecular medicine reports (01-05-2022)“…Autism spectrum disorder (ASD) is a lifelong neurodevelopmental condition characterized by impaired social interaction, compromised communication, and…”
Get full text
Journal Article -
6
Abstract 4595: HSK41959-2: An oral MTA-cooperative PRMT5 inhibitor for MTAP deleted cancer
Published in Cancer research (Chicago, Ill.) (22-03-2024)“…Methylthioadenosine phosphorylase (MTAP) homozygous deletion occurs in 10-15% of all human cancers. Loss of MTAP result in methylthioadenosine (MTA)…”
Get full text
Journal Article -
7
A Novel Plant-Produced Asialo-rhuEPO Protects Brain from Ischemic Damage Without Erythropoietic Action
Published in Translational stroke research (01-04-2022)“…Mammalian cell-produced recombinant human erythropoietin (rhuEPO M ) has been shown to be a multimodal neuroprotectant targeting an array of key pathological…”
Get full text
Journal Article -
8
Abstract LB262: HSK38008: An oral AR-V7 degrader for metastatic castration-resistant prostate cancer
Published in Cancer research (Chicago, Ill.) (14-04-2023)“…The androgen deprivation therapy (ADT) alone and its combination with hormone therapy that block AR signaling (e.g., enzalutamide or abiraterone) are effective…”
Get full text
Journal Article -
9
Deletion of mitochondrial uncoupling protein 2 exacerbates mitophagy and cell apoptosis after cerebral ischemia and reperfusion injury in mice
Published in International journal of medical sciences (01-01-2020)“…Objective: Uncoupling protein 2 (UCP2) is a member of inner mitochondrial membrane proteins and deletion of UCP2 exacerbates brain damage after cerebral…”
Get full text
Journal Article